Henrik Lindman
Adjunct Professor at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Henrik Lindman
- Mobile phone:
- +46 70 688 48 78
- E-mail:
- henrik.lindman@igp.uu.se
- Visiting address:
- Akademiska sjukhuset, ing 100/101, plan 1
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ing 100/101
751 85 Uppsala
Short presentation
MD, PhD, Ass. Professor in Oncology, Uppsala University
Department of Oncology, Akademiska sjukhuset, Senior registrar
Head of Breast Cancer service. Department of Oncology, Uppsala University Hospital
Chairman of the Uppsala-Örebro region Breast Group
Chairman of the Uppsala-Örebro region Breast Oncology Group
Vice chairman of the Swedish Breast Cancer Group (SweBCG)
Member of the board of the Swedish Association of Breast Oncologists

Publications
Recent publications
-
Part of Oncology and Therapy, p. 95-112, 2026
- DOI for Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review
- Download full text (pdf) of Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review
-
Part of Journal of Geriatric Oncology, 2026
- DOI for CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
- Download full text (pdf) of CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
-
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Part of Nature, p. 1088-1096, 2026
- DOI for Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
- Download full text (pdf) of Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
-
Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
Part of Internet Interventions, 2026
- DOI for Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
- Download full text (pdf) of Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
-
Part of European Journal of Cancer, 2026
- DOI for Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen
- Download full text (pdf) of Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen
All publications
Articles in journal
-
Part of Oncology and Therapy, p. 95-112, 2026
- DOI for Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review
- Download full text (pdf) of Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative Review
-
Part of Journal of Geriatric Oncology, 2026
- DOI for CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
- Download full text (pdf) of CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
-
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Part of Nature, p. 1088-1096, 2026
- DOI for Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
- Download full text (pdf) of Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
-
Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
Part of Internet Interventions, 2026
- DOI for Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
- Download full text (pdf) of Affect-focused psychodynamic psychotherapy for mothers diagnosed with cancer: A feasibility study
-
Part of European Journal of Cancer, 2026
- DOI for Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen
- Download full text (pdf) of Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen
-
A human pan-disease blood atlas of the circulating proteome
Part of Science, 2025
-
Part of The Breast, 2025
- DOI for Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study
- Download full text (pdf) of Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study
-
Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer
Part of Journal of the National Cancer Institute, p. 1125-1133, 2025
- DOI for Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer
- Download full text (pdf) of Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer
-
Part of The Breast, 2025
- DOI for Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Download full text (pdf) of Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
-
Part of The Lancet Regional Health, 2024
- DOI for Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study
- Download full text (pdf) of Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study
-
Part of Journal of Clinical Oncology, 2024
-
Part of The FASEB Journal, 2024
-
Part of Future Oncology, p. 2937-2948, 2024
- DOI for Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients
- Download full text (pdf) of Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients
-
Part of FASEB Bioadvances, p. 454-466, 2024
- DOI for AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis
- Download full text (pdf) of AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis
-
Part of JAMA Network Open, 2024
- DOI for Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial
- Download full text (pdf) of Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial
-
Lessons learned from an unsuccessful decentralized clinical trial in Oncology
Part of npj Digital Medicine, 2024
- DOI for Lessons learned from an unsuccessful decentralized clinical trial in Oncology
- Download full text (pdf) of Lessons learned from an unsuccessful decentralized clinical trial in Oncology
-
Part of BMC Cancer, 2024
- DOI for Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry
- Download full text (pdf) of Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry
-
Part of Breast Cancer Research and Treatment, p. 299-308, 2024
- DOI for The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
- Download full text (pdf) of The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
-
Next generation pan-cancer blood proteome profiling using proximity extension assay
Part of Nature Communications, 2023
- DOI for Next generation pan-cancer blood proteome profiling using proximity extension assay
- Download full text (pdf) of Next generation pan-cancer blood proteome profiling using proximity extension assay
-
Part of The Breast, p. 63-68, 2023
- DOI for Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
- Download full text (pdf) of Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
-
Part of Clinical Cancer Research, p. 532-540, 2023
-
Part of International Journal of Clinical Oncology, p. 89-98, 2023
-
Part of Frontiers in Oncology, 2023
- DOI for Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR plus ), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
- Download full text (pdf) of Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR plus ), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
-
Part of Frontiers in Oncology, 2023
- DOI for Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
- Download full text (pdf) of Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
-
Part of Acta Oncologica, p. 1045-1051, 2023
- DOI for Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS)
- Download full text (pdf) of Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS)
-
Part of Journal of Nuclear Medicine, p. 1364-1370, 2023
- DOI for Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
- Download full text (pdf) of Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
-
Part of Nature Communications, 2023
- DOI for Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
- Download full text (pdf) of Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
-
Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.
Part of Oncoimmunology, 2022
- DOI for Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.
- Download full text (pdf) of Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.
-
Part of The Lancet Regional Health, 2022
- DOI for Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study
- Download full text (pdf) of Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study
-
Part of Cancers, 2022
- DOI for Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study
- Download full text (pdf) of Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study
-
Part of BMC Cancer, 2022
- DOI for Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes - an observational cohort study in Sweden
- Download full text (pdf) of Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes - an observational cohort study in Sweden
-
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Part of Proceedings of the National Academy of Sciences of the United States of America, 2022
- DOI for Noninvasive detection of any-stage cancer using free glycosaminoglycans
- Download full text (pdf) of Noninvasive detection of any-stage cancer using free glycosaminoglycans
-
Part of British Journal of Cancer, p. 1401-1409, 2022
- DOI for Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
- Download full text (pdf) of Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
-
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study
Part of British Journal of Cancer, p. 720-725, 2022
- DOI for Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study
- Download full text (pdf) of Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study
-
Part of npj Breast Cancer, 2022
- DOI for RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
- Download full text (pdf) of RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
-
Part of Journal of Clinical Oncology, p. 1051-1058, 2022
- DOI for Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
- Download full text (pdf) of Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
-
Part of The Breast, p. 157-164, 2021
- DOI for Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
- Download full text (pdf) of Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
-
Part of Scandinavian Journal of Medicine and Science in Sports, p. 1144-1159, 2021
- DOI for Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial
- Download full text (pdf) of Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial
-
Part of JAMA Oncology, p. 1360, 2021
-
Part of Acta Oncologica, p. 1604-1610, 2021
- DOI for Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry
- Download full text (pdf) of Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry
-
Part of Medicine, 2021
- DOI for Effects of heavy-load resistance training during (neo-)adjuvant chemotherapy on muscle cellular outcomes in women with breast cancer
- Download full text (pdf) of Effects of heavy-load resistance training during (neo-)adjuvant chemotherapy on muscle cellular outcomes in women with breast cancer
-
Part of EJNMMI Research, 2020
- DOI for Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
- Download full text (pdf) of Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
-
Part of Acta Oncologica, p. 825-832, 2020
-
Part of Clinical Cancer Research, p. 2603-2614, 2020
-
Part of Scientific Reports, 2019
- DOI for Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
- Download full text (pdf) of Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
-
Part of Breast Cancer Research and Treatment, p. 459-467, 2019
- DOI for Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
- Download full text (pdf) of Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
-
Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 12-23, 2019
-
Part of Cancer Chemotherapy and Pharmacology, p. 301-318, 2019
-
Part of Acta Oncologica, p. 187-194, 2018
- DOI for U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
- Download full text (pdf) of U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
-
Part of British Journal of Clinical Pharmacology, p. 490-500, 2018
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Part of JAMA Oncology, p. 1199-1206, 2018
-
Part of Acta Oncologica, p. 935-940, 2018
- DOI for Good adherence to adjuvant endocrine therapy in early breast cancer: a population-based study based on the Swedish prescribed Drug Register
- Download full text (pdf) of Good adherence to adjuvant endocrine therapy in early breast cancer: a population-based study based on the Swedish prescribed Drug Register
-
Part of European Journal of Surgical Oncology, p. 951-956, 2018
-
Part of European Journal of Cancer, 2018
-
Part of JAMA Oncology, p. 423-424, 2018
-
Part of European Journal of Cancer, p. 79-86, 2018
-
Part of British Journal of Surgery, 2018
- DOI for Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- Download full text (pdf) of Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
-
Part of Cancer Research, 2018
-
Part of Breast Cancer Research and Treatment, p. 349-355, 2018
- DOI for Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
- Download full text (pdf) of Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 1337-1346, 2017
- DOI for Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
- Download full text (pdf) of Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
-
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer
Part of Annals of Oncology, 2017
-
Breast cancer in young women and prognosis: How important are proliferation markers?
Part of European Journal of Cancer, p. 278-289, 2017
-
Part of JAMA Oncology, p. 793-800, 2017
-
Part of Acta Oncologica, p. 614-617, 2017
-
Part of Cancer Research, 2017
-
Part of The Breast, p. 27-33, 2016
-
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT
Part of Theranostics, p. 262-271, 2016
- DOI for Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT
- Download full text (pdf) of Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [(68)Ga]ABY-025 Affibody PET/CT
-
Long-term outcome in young women with breast cancer: a population-based study
Part of Breast Cancer Research and Treatment, p. 131-143, 2016
- DOI for Long-term outcome in young women with breast cancer: a population-based study
- Download full text (pdf) of Long-term outcome in young women with breast cancer: a population-based study
-
Good manufacturing practice production of [68Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.
Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 135-153, 2016
-
Part of Journal of Nuclear Medicine, p. 867-871, 2016
-
Time and value of chemotherapy administration burden in a Swedish hospital
Part of Cancer Research, 2016
-
The development of the metastatic site pattern during time in different subtypes of breast cancer
Part of Cancer Research, 2016
-
Nordic trip, a randomized phase 3 study in early triple negative breast cancer
Part of Cancer Research, 2016
-
Mutanome Engineered RNA Immunotherapy (MERIT)
Part of HUMAN GENE THERAPY CLINICAL DEVELOPMENT, p. 84-86, 2015
-
Part of Supportive Care in Cancer, p. 2965-2972, 2015
-
Part of Cancer Research, 2015
-
Part of Journal of Clinical Oncology, 2015
-
Multicenter Reproducibility of F-18-Fluciclatide PET Imaging in Subjects with Solid Tumors
Part of Journal of Nuclear Medicine, p. 1855-1861, 2015
-
Part of Journal of labelled compounds & radiopharmaceuticals, 2015
-
The Mutanome Engineered RNA Immuno-Therapy (MERIT) project
Part of Cancer Research, 2015
-
Breast cancer in young women - age a risk factor only in those not given chemotherapy
Part of The Breast, 2014
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Radiation dosimetry and tracer kinetic analysis of Ga-68-ABY025 Affibody in breast cancer patients
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Measuring HER2-expression in metastatic breast cancer using 68Ga-ABY025 PET/CT
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Part of Pharmaceutical research, p. 3390-3403, 2014
-
Part of Acta Oncologica, p. 186-194, 2014
-
Part of Journal of Nuclear Medicine, p. 730-735, 2014
- DOI for First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule
- Download full text (pdf) of First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the In-111-ABY-025 Affibody Molecule
-
Part of BMC Cancer, p. 512, 2013
- DOI for Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
- Download full text (pdf) of Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
-
Part of Breast Cancer Research and Treatment, p. 467-473, 2013
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012
-
Test-retest reproducibility of [F-18]fluciclatide PET imaging in subjects with solid tumors
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012
-
Part of Breast Cancer Research and Treatment, p. 367-373, 2012
-
Part of Journal of Clinical Oncology, p. 11-18, 2012
-
Part of British Journal of Cancer, p. 899-902, 2011
-
Part of Acta Oncologica, p. 329-337, 2011
-
Part of Acta Oncologica, p. 35-41, 2011
-
Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer
Part of American Journal of Obstetrics and Gynecology, p. 260-7, 2011
-
Part of Cancer Chemotherapy and Pharmacology, p. 839-848, 2010
- DOI for Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression
- Download full text (pdf) of Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression
-
Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer
Part of Upsala Journal of Medical Sciences, p. 116-120, 2009
-
Health care costs for treatment of disseminated breast cancer
Part of European Journal of Cancer, p. 1987-1991, 2009
-
Part of European Journal of Cancer, p. 3198-3204, 2009
-
Part of The Lancet Oncology, p. 1145-1151, 2009
-
Part of Acta Oncologica, p. 740-6, 2008
-
Part of Investigational new drugs, p. 195-204, 2008
-
Part of Annals of Oncology, p. 694-700, 2007
-
Part of Acta Oncologica, p. 165-171, 2007
-
Part of J Clin Oncol, p. 413-21, 2005
-
Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging
Part of Acta Radiologica, p. 198-206, 2001
Chapters in book
-
Metastatic breast cancer: diagnosis and oncological management
Part of Breast cancer management for surgeons, p. 357-383, Springer, 2023